Literature DB >> 7786886

An open-label study of famotidine as a treatment for schizophrenia.

H A Whiteford, T J Stedman, J J McGrath, J Welham, S Pond.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7786886      PMCID： PMC1188693     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  5 in total

1.  Effect of famotidine on deficit symptoms of schizophrenia.

Authors:  R Kaminsky; T M Moriarty; J Bodine; D E Wolf; M Davidson
Journal:  Lancet       Date:  1990-06-02       Impact factor: 79.321

2.  Modification of the radioreceptor assay technique for estimation of serum neuroleptic drug levels leads to improved precision and sensitivity.

Authors:  M L Rao
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Effects of nifedipine on psychosis and tardive dyskinesia in schizophrenic patients.

Authors:  T J Stedman; H A Whiteford; D Eyles; J L Welham; S M Pond
Journal:  J Clin Psychopharmacol       Date:  1991-02       Impact factor: 3.153

4.  Famotidine as an adjunct treatment of resistant schizophrenia.

Authors:  L K Oyewumi; D Vollick; H Merskey; C Plumb
Journal:  J Psychiatry Neurosci       Date:  1994-03       Impact factor: 6.186

5.  Research diagnostic criteria: rationale and reliability.

Authors:  R L Spitzer; J Endicott; E Robins
Journal:  Arch Gen Psychiatry       Date:  1978-06
  5 in total
  2 in total

1.  Apparent absence of famotidine-antipsychotic drug interactions in patients with chronic schizophrenia.

Authors:  G D Prell; R B Rosse; S I Deutsch
Journal:  J Psychiatry Neurosci       Date:  1996-01       Impact factor: 6.186

Review 2.  International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.

Authors:  Pertti Panula; Paul L Chazot; Marlon Cowart; Ralf Gutzmer; Rob Leurs; Wai L S Liu; Holger Stark; Robin L Thurmond; Helmut L Haas
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.